United Bank (Virginia)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Hold |
18,098
| – | – | 0.14% | 70 |
|
|
2025
Q4 | $976K | Hold |
18,098
| – | – | 0.13% | 74 |
|
|
2025
Q3 | $816K | Hold |
18,098
| – | – | 0.1% | 76 |
|
|
2025
Q2 | $838K | Sell |
18,098
-1,000
| -5% | -$49.1K | 0.1% | 77 |
|
|
2025
Q1 | $1.16M | Hold |
19,098
| – | – | 0.15% | 70 |
|
|
2024
Q4 | $1.08M | Sell |
19,098
-200
| -1% | -$11.2K | 0.13% | 69 |
|
|
2024
Q3 | $998K | Hold |
19,298
| – | – | 0.12% | 71 |
|
|
2024
Q2 | $801K | Sell |
19,298
-30
| -0.2% | -$1.34K | 0.1% | 76 |
|
|
2024
Q1 | $1.05M | Sell |
19,328
-490
| -2% | -$25K | 0.13% | 65 |
|
|
2023
Q4 | $1.02M | Sell |
19,818
-5,029
| -20% | -$264K | 0.13% | 64 |
|
|
2023
Q3 | $1.44M | Hold |
24,847
| – | – | 0.19% | 53 |
|
|
2023
Q2 | $1.59M | Sell |
24,847
-6,784
| -21% | -$455K | 0.2% | 53 |
|
|
2023
Q1 | $2.19M | Sell |
31,631
-538
| -2% | -$37.9K | 0.28% | 51 |
|
|
2022
Q4 | $2.31M | Sell |
32,169
-2,624
| -8% | -$198K | 0.32% | 45 |
|
|
2022
Q3 | $2.47M | Buy |
34,793
+6,434
| +23% | +$467K | 0.38% | 40 |
|
|
2022
Q2 | $2.18M | Buy |
28,359
+500
| +2% | +$38.1K | 0.33% | 46 |
|
|
2022
Q1 | $2.03M | Sell |
27,859
-1,854
| -6% | -$124K | 0.27% | 49 |
|
|
2021
Q4 | $1.85M | Sell |
29,713
-1,681
| -5% | -$98.6K | 0.23% | 54 |
|
|
2021
Q3 | $1.86M | Buy |
31,394
+1,231
| +4% | +$81.1K | 0.25% | 53 |
|
|
2021
Q2 | $2.02M | Sell |
30,163
-183
| -0.6% | -$11.9K | 0.27% | 50 |
|
|
2021
Q1 | $1.92M | Sell |
30,346
-4,182
| -12% | -$260K | 0.26% | 57 |
|
|
2020
Q4 | $2.14M | Buy |
34,528
+4,663
| +16% | +$287K | 0.32% | 50 |
|
|
2020
Q3 | $1.8M | Buy |
29,865
+667
| +2% | +$40.1K | 0.31% | 45 |
|
|
2020
Q2 | $1.72M | Buy |
29,198
+1,598
| +6% | +$95.6K | 0.31% | 49 |
|
|
2020
Q1 | $1.54M | Sell |
27,600
-521
| -2% | -$31.8K | 0.33% | 49 |
|
|
2019
Q4 | $1.8M | Buy |
28,121
+2,021
| +8% | +$116K | 0.31% | 51 |
|
|
2019
Q3 | $1.32M | Buy |
26,100
+888
| +4% | +$41.7K | 0.24% | 60 |
|
|
2019
Q2 | $1.14M | Sell |
25,212
-5,363
| -18% | -$250K | 0.19% | 67 |
|
|
2019
Q1 | $1.46M | Buy |
30,575
+24,000
| +365% | +$1.2M | 0.26% | 54 |
|
|
2018
Q4 | $341K | Hold |
6,575
| – | – | 0.07% | 116 |
|
|
2018
Q3 | $408K | Hold |
6,575
| – | – | 0.09% | 91 |
|
|
2018
Q2 | $364K | Sell |
6,575
-6,638
| -50% | -$359K | 0.08% | 92 |
|
|
2018
Q1 | $836K | Sell |
13,213
-537
| -4% | -$34.5K | 0.19% | 57 |
|
|
2017
Q4 | $843K | Buy |
13,750
+6,938
| +102% | +$434K | 0.21% | 64 |
|
|
2017
Q3 | $434K | Hold |
6,812
| – | – | 0.41% | 34 |
|
|
2017
Q2 | $380K | Hold |
6,812
| – | – | 0.37% | 37 |
|
|
2017
Q1 | $370K | Hold |
6,812
| – | – | 0.38% | 36 |
|
|
2016
Q4 | $398K | Hold |
6,812
| – | – | 0.48% | 38 |
|
|
2016
Q3 | $367K | Hold |
6,812
| – | – | 0.39% | 43 |
|
|
2016
Q2 | $501K | Hold |
6,812
| – | – | 0.49% | 42 |
|
|
2016
Q1 | $435K | Hold |
6,812
| – | – | 0.44% | 43 |
|
|
2015
Q4 | $469K | Hold |
6,812
| – | – | 0.57% | 35 |
|
|
2015
Q3 | $403K | Buy |
+6,812
| New | +$432K | 0.55% | 37 |
|
Other funds holding BMY
VCM
VPM
United Bank (Virginia)'s BMY Position: Q1 2026 in Review
United Bank (Virginia) held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 18,098 shares worth $1.1M. The position accounts for 0.14% of the portfolio, ranked #70.
United Bank (Virginia) first reported a position in BMY in Q3 2015 and has held it in 43 quarters since. The position peaked at $2.47M in Q3 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- United Bank (Virginia) held 18,098 shares of Bristol-Myers Squibb worth $1.1M as of Q1 2026.
- United Bank (Virginia) left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.14% of United Bank (Virginia)'s portfolio in Q1 2026, its #70 holding.
- United Bank (Virginia) first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 43 quarters since.
- United Bank (Virginia)'s Bristol-Myers Squibb position peaked at $2.47M in Q3 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on United Bank (Virginia)'s 13F filing for Q1 2026, filed 11 May 2026.